Theriva Biologics, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Theriva Biologics, Inc. (TOVX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$199.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2016-11-01
- Theriva Biologics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$154.00K.
- Theriva Biologics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$1.00K.
- Theriva Biologics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was -$44.00K.
- Theriva Biologics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-09-30 was -$396.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month |
|---|---|---|---|
| 2016-09-30 | -$154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$155.00K derived: sum of 2 quarters · filed 2016-11-01 | -$199.00K 10-Q · filed 2016-11-01 |
| 2016-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$45.00K 10-Q · filed 2016-08-03 | |
| 2016-03-31 | -$44.00K 10-Q · filed 2016-05-05 | ||
| 2015-09-30 | -$396.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$439.00K derived: sum of 2 quarters · filed 2016-11-01 | -$457.00K 10-Q · filed 2016-11-01 |
| 2015-06-30 | -$43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$61.00K 10-Q · filed 2016-08-03 | |
| 2015-03-31 | -$18.00K 10-Q · filed 2016-05-05 | ||
| 2014-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$39.00K derived: sum of 2 quarters · filed 2014-11-14 | -$43.00K 10-Q · filed 2014-11-14 |
| 2014-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$21.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$4.00K 10-Q · filed 2014-05-15 | ||
| 2013-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$22.00K derived: sum of 2 quarters · filed 2014-11-14 | -$25.00K 10-Q · filed 2014-11-14 |
| 2013-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$13.00K 10-Q · filed 2014-08-14 | |
| 2013-03-31 | -$3.00K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |